Companies / HGH
HEARTLAND GROUP HOLDINGS LIMITED
ASX:HGHBanks945.2M shares on issueASX (delayed) · as of 28 July 2026$1.03price · delayed$961.7Mmarket cap · indicative
A
Dilution grade
No major dilution pressure signals in current disclosures
Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)1.6%
Raise cadence (24m)0 cash raises
Options & rights overhang0.7% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone
HEARTLAND GROUP HOLDINGS LIMITED had 945M ordinary shares as of March 2026, a 1.6% change since April 2024. The company did not raise capital in the recent 24-month window. Options and rights could convert into 7M new shares, equal to 0.7% of the current share count, with 0% in the money. The company does not have a current quarterly cash report on record, so no quarter-end cash balance or funding-runway figure is disclosed. No proposed securities issues (Appendix 3B) are currently pending.
AI-generated summary of this page's cited filings · updated 28 July 2026
0.7%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
—
Cash cover · not a quarterly filer
Shares on issue — last 2 years
Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 945.2M per ASX (delayed) (28 July 2026).
Cash runway
Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 19 Mar 2026 | 2A · quoted issue | HGH : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 945.2M | Appendix 2A |
| 28 Sept 2025 | 3H · cancellation | HGH : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 942.5M | Appendix 3H |
| 11 Sept 2025 | 2A · quoted issue | HGH : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 942.5M | Appendix 2A |
| 7 July 2025 | 3H · cancellation | HGH : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 940.1M | Appendix 3H |
| 20 Mar 2025 | 2A · quoted issue | HGH : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 940.1M | Appendix 2A |
Paid plan
Full issuance history
Join the waitlist
Capital raises
No equity raises in the last 24 months.
Paid plan
Full raise history
Join the waitlist
Pending proposed issues
No proposed issues (Appendix 3B) currently pending.
Options & convertible securities
0.7%
Total overhang · of current shares
0.0%
In the money · at current price
6.6M
Potential new shares
—
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Join the waitlist
Director dealings
Ownership
Free account
Top-20 holders & substantial holder notices
Sign up free — coming soon
Latest announcements
22 July 2026Heartland Special Shareholder Meeting date
30 June 2026Heartland FY2026 results announcement date
16 June 2026Heartland Special Shareholder Meeting date
14 June 2026HGH confirms satisfaction of initial conditions
19 Mar 2026Notification of Allotment of Securities
15 Mar 2026Update - Dividend/Distribution - HGH
25 Feb 2026Dividend/Distribution - HGH
27 Jan 2026Half year results announcement date
21 Dec 2025Notification of Allotment of Securities
3 Dec 2025Ceasing to be a substantial holder
12 Nov 2025Results of Heartland 2025 AGM
12 Nov 2025Heartland 2025 Annual General Meeting
10 Oct 2025Ongoing Disclosure Notice - S Beckett
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.